© 2020 HealthCore Inc.
menu
search
menu
search
September 16-17 | Virtual Conference

ICPE All Access 2020

HealthCore is a proud sponsor of the International Society for Pharmacoepidemiology’s 2020 International Conference on Pharmacoepidemiology and Therapeutic Risk Management. This year’s virtual conference, ICPE All Access, will offer live stream and on-demand content plus skills courses, posters, and an exhibit hall. Content will be available for viewing by registrants through December 31, 2020.

HealthCore’s researchers will present on a variety of topics including drug safety, validation, machine learning, pregnancy, and more.

 

HealthCore ICPE All Access Presentations

Virtual Poster Presentations

PO-0121 | Real-World Safety of Palbociclib in Breast Cancer Patients in the United States
Beachler DC1, de Luise C3, Jamal-Allial A2, Yin R4, Taylor DH1, Lanes S1
1HealthCore, Inc., Wilmington, DE, United States; 2HealthCore, Inc., Watertown, MA, United States; 3Pfizer Inc., New York, NY, United States; 4Anthem, Inc., Andover, MA, United States

PO-2528 | Selecting an Appropriate Comparator Group in Vaccine Cohort Studies of Older Adults: Recombinant Zoster Vaccine as an Example
Han J1, Jamal-Allial A2, McMahill-Walraven C3, Brown J4, Yih K4
1GlaxoSmithKline, Rockville, MD, United States; 2HealthCore, Inc., Watertown, MA, United States; 3Healthagen, Blue Bell, PA, United States; 4Harvard Pilgrim Health Care, Boston, MA, United States

PO-3811 | Validation of Acute Outcomes among Patients with Type 2 Diabetes Mellitus in US Medicare: A Pilot Study
Danysh HE1, Layton JB2, Beachler DC3, Arana A4, Pladevall-Vila M4, Schmid R5, Calingaert B2, Ziemiecki R2, Hunt PR6, Gilsenan A2, Johannes C1
1RTI Health Solutions, Waltham, MA United States; 2RTI Health Solutions, Research Triangle Park, NC, United States; 3HealthCore, Inc., Wilmington, DE, United States; 4RTI Health Solutions, Barcelona, Spain; 5South Bend Clinic, Granger, IN, United States; 6AstraZeneca, Gaithersburg, MD, United States

PO-3815 | Validation of Breast Cancer and Bladder Cancer among Patients with Type 2 Diabetes Mellitus in Medicare: A Pilot Study
Danysh HE1, Gilsenan A2, Beachler DC3, Kaye JA1, de Albeniz Martinez XG4, Schmid R5, Hunter S2, Hunt PR6, Aguado J4, Calingaert B2, Layton JB2, Gutierrez L4
1RTI Health Solutions, Waltham, MA, United States; 2RTI Health Solutions, Research Triangle Park, NC, United States; 3HealthCore, Inc., Wilmington, DE, United States; 4RTI Health Solutions, Barcelona, Spain; 5South Bend Clinic, Granger, IN, United States; 6AstraZeneca, Gaithersburg, MD, United States

PO-4153 | Identifying Cohorts of Patients with Type 2 Diabetes Mellitus Initiating Dapagliflozin in Three Data Sources
Layton JB1, Zhou CK2, Danysh HE1, Beachler DC2, Ziemiecki R1, Dinh J2, Yin R2, Calingaert B1, Hunt PR3, Gilsenan AW1, Johannes CB1
1RTI Health Solutions, Research Triangle Park, NC, United States; 2HealthCore, Inc., Wilmington, DE, United States; 3AstraZeneca, Gaithersburg, MD, United States

PO-4200 | Description of Acute Kidney Injury and Breast Cancer Outcome Validation Processes Across Three Databases
Dinh J1, Danysh HE2, Johannes C2, Gutierrez L2, Schmid R3, Arana A2, Kaye JA2, Pladevall-Vila M2, de Albeniz XG2, Hunt PR4, Gilsenan A2, Beachler DC1, Zhou CK1
1HealthCore, Inc., Wilmington, DE, United States; 2RTI Health Solutions, Research Triangle Park, NC, United States; 3South Bend Clinic, Granger, IN, United States; 4AstraZeneca, Gaithersburg, MD, United States

 

Oral Papers
On-Demand Sessions

SAFETY END POINTS
OR-0106 | Development and Validation of a Machine Learning Algorithm to Identify Anaphylaxis in US Administrative Claims Data
Beachler DC1, Taylor DH1, Anthony MS2, Yin R1, Li L1, Saltus CW2, Li L3, Shaunik A3, Walsh KE4, Lanes S1, Rothman KJ2, Johannes C2, Aroda V5, Carr W6, Goldberg P7, Accardi A8, O’Shura JS9, Sharma K3, Juhaeri J3, Wu C3
1HealthCore, Inc., Wilmington, DE, United States; 2RTI Health Solutions, Research Triangle Park, NC, United States; 3Sanofi, Bridgewater, NJ, United States; 4Cincinnati Children’s Hospital Medical Center, Cincinnati OH, United States; 5Harvard, Cambridge, MA, United States; 6Allergy & Asthma Associates of Southern California, Mission Viejo, CA, United States; 7Allergy Partners of Central Indiana, Indianapolis, IN, United States; 8Scripps Health and SMHE, Encinitas, CA, United States; 9Lower Bucks Hospital, Bristol, PA, United States

PREGNANCY AND LACTATION
OR-4957 | Developing Methodology to Estimate Gestational Age Using Administrative Claims
Jamal-Allial A1, He X1, Dinh J2, Avula R3, Lanes S3
1HealthCore, Inc., Watertown, MA, United States; 2HealthCore, Inc., Alexandria, VA, United States; 3HealthCore, Inc., Wilmington, DE, United States

 

Skills Course
On-Demand Sessions

SC25 | Using Pharmacoepidemiology Database Resources to Address Drug Safety Research

Database Selection Workshop Activity
Kevin Haynes, PharmD, MSCE
HealthCore, Inc., Wilmington, DE, United States

Data Validation Approaches in Pharmacoepidemiology
Daniel Beachler, PhD, MHS
HealthCore, Inc., Wilmington, DE, United States

 

View all HealthCore presentations at https://www.eventscribe.com/2020/ICPEAllAccess/. Registration is required.